drugset / Trial / NCT04697888
Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
NaSingle-groupOpen-labelTreatment
Summary
To provide parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, Omegaven®) to patients with liver disease (PNALD).
Timeline
- Start
- 2013-04
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omegaven | Other / unclassified | 1 g/kg | Intravenous |